Artificial Intelligence Combined With 3D-Preformed Chest Wall Defection Reconstruction System in Chest Wall Tumor Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorWu Weiming

About this trial

Chest wall tumors should be completely resection as much as possible while malignant chest wall tumors should be extensively resection. If not completely resection, it will recur in the short time and affect the patient's survival. At present, the surgical resection range mainly relies on preoperative imaging examination and the experience of the surgeon. It lacks precise guidance. This can easily lead to incomplete resection. In addition, the reconstruction materials required for reconstruct the excised chest wall defection are often generated in a standardized manner, lacking intraoperative adjustability. To address this clinical issue, we plan to carry out the research on the application of artificial Intelligence (AI) assisted chest wall tumor resection combined with personalized 3D preformed chest wall defection reconstruction system in chest wall tumor surgery.

Eligibility criteria

Qualifiers

18-70 years old, male or female not limited

Anesthesia ASA score I-II

Malignant tumor of soft tissue in the chest

Malignant tumors of ribs, rib cartilage, and sternum

Disqualifiers

Patients with distant metastasis detected during preoperative examination

Inoperable tumor

During the examination, it was discovered that the patient had another type of malignant tumor present

ECOG 4

Trial design

Treatments tested in this trial

  • Chest wall tumor resection by the artificial intelgent assistent

Treatment groups

50 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Wu Weiming

Lead sponsor

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Sponsor institution